Methods and compositions to graft bone using iron excipients
US-2024000996-A1 · Jan 4, 2024 · US
US10449270B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10449270-B2 |
| Application number | US-201715443003-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 27, 2017 |
| Priority date | Jun 22, 2006 |
| Publication date | Oct 22, 2019 |
| Grant date | Oct 22, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The subject invention concerns non-degradable three dimensional porous collagen scaffolds and coatings. These scaffolds can be prepared around sensors for implantation into a body. A specific embodiment of the invention concerns implantable glucose sensors. Sensors comprising a collagen scaffold of the invention have improved biocompatibility by minimizing tissue reactions while stimulating angiogenesis. The subject invention also concerns methods for preparing collagen scaffolds of the invention. The subject invention also concerns sensors that have a collagen scaffold of the invention around the exterior of the sensor.
Opening claim text (preview).
We claim: 1. A device having enhanced biocompatibility for implantation into the body or tissue of a person or animal, wherein said device comprises a biocompatible collagen scaffold and/or coating embedded in a nordihydroguaiaretic acid (NDGA) bisquinone polymer matrix; and wherein said device comprises a sensor. 2. The device according to claim 1 , wherein said device is a glucose sensor. 3. The device according to claim 1 , wherein said device comprises an epoxy coating underneath said collagen scaffold and/or coating. 4. The device according to claim 3 , wherein said epoxy coating is an epoxy-polyurethane coating. 5. The device according to claim 1 , wherein said collagen scaffold and/or coating comprises open pores of about 10 μm to about 200 μm in diameter (mean). 6. The device according to claim 5 , wherein the mean pore size of said collagen scaffold and/or coating is about 60 μm or less in diameter. 7. The device according to claim 5 , wherein the mean pore size of said collagen scaffold and/or coating is between about 40 μm to about 80 μm in diameter. 8. The device according to claim 5 , wherein said pores are regularly distributed in said collagen scaffold and/or coating. 9. The device according to claim 5 , wherein said pores form an interconnected pore structure in said collagen scaffold and/or coating. 10. The device according to claim 1 , wherein said collagen scaffold and/or coating comprises an antimicrobial, anti-inflammatory, and/or angiogenic compound, drug or growth factor.
Treatment of implants to prevent calcification or mineralisation in vivo · CPC title
containing macromolecular fillers · CPC title
Porous materials, {e.g. foams or sponges} · CPC title
Macromolecular materials · CPC title
Macromolecular materials · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.